You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生科(688366.SH):利康瑞擬增資擴股實施員工持股計劃
格隆匯 07-31 16:33

格隆匯7月31日丨昊海生科(688366.SH)公佈,公司全資子公司上海利康瑞生物工程有限公司(“利康瑞”)擬以人民幣2元/股的價格新增註冊資本人民幣7500萬元,上海順安緣生物科技合夥企業(有限合夥)(“順安緣”)(尚在設立中)、上海康鼎辰生物科技合夥企業(有限合夥)(“康鼎辰”)作為兩個員工持股平台,擬分別以人民幣7000萬元、人民幣8000萬元各認購利康瑞註冊資本人民幣3500萬元、人民幣4000萬元,共計增資人民幣1.5億元。此次交易完成後,昊海生科持有利康瑞70%股權,順安緣、康鼎辰分別持有利康瑞14%、16%股權,利康瑞的註冊資本由人民幣1.75億元增加至人民幣2.5億元,利康瑞由公司全資子公司變為公司控股子公司,公司合併報表範圍未發生變化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account